Advanced drug delivery systems (DDS) are easily designed following a photoiterative strategy. Multifunctional polymers are obtained by coupling building blocks of interest to an alkynated PCL platform via an efficient thiol-yne photoaddition. Fine tuning over the design is achieved as illustrated with targeting and enzyme-responsive DDS.
Introduction
Efficient and simple modulation of DDS surfaces is highly desirable for enhanced in vivo efficacy. It is in particular the case for cancer treatments where DDS should demonstrate highly prolonged circulation time in blood, increased accumulation in tumor and sufficient internalization into cancer cells. These multiple requirements are still the driving force for nanovectors research and the development of methodologies allowing the multifunctionalization of polymers and biomaterial surfaces is therefore a key point for the translation of advanced DDS from bench to patient. [1] However, despite a tremendous variety of smart DDS described in literature, very few are close to clinic, with only the simplest systems finding their way to the market like the PEG-PLA-based Genexol®. [2] This example paves the way to future products and confirms the potential of polyester-based DDS. It highlights however one major problem, which is the difficulty to make advanced DDS a marketable reality due to various factors. Firstly, the low gain of efficiency reported for the more advanced targeting DDS compared to the classical DDS using EPR effect for accumulation. [3] Here, systematic and more transversal approaches should allow to overcome this pitfall. [4] Secondly, the fact that many actors have to converge to allow such development taking into account industry dynamics, regulation and ethical issues. [5] Last, the difficulty to modify the exiting approved polymers, especially aliphatic polyesters, to efficiently manufacture such advanced DDS with reproducibility and cost-effectiveness.
In fact, classical polyesters that are FDA-approved for medical devices or drug formulations, like PLA, PGA, PCL and their copolymers, do not exhibit functional groups with exception to the terminal hydroxyl or carboxyl groups. To solve this lack of reactivity, various methods have been implemented including post-polymerization methods like wet chemistry under mild degrading conditions (aminolysis, hydrolysis) [6] or plasma activation, [7] and synthesis of lactones bearing functional groups. [8] [9] [10] However, the post-polymerization strategies generally face problems of chain degradation and limited number of accessible reactive groups, whereas the lactone strategy faces problems of low yield due to multistep reactions and challenging purifications and, depending on the substituent, moderate to low monomer conversion and polymerization degrees. Another problem resides in the variety of chemistries, and therefore reacting groups, that may be required to efficiently generate multifunctional polymeric vectors. There is therefore a challenge to yield advanced DDS (i) based on cheap, stable and versatile polymeric platforms on one hand, and (ii) based on simple and industry-transferable methodologies. Considering these aspects, our group previously reported on the synthesis of a multi-alkynated PCL (PCL-yne) following a post-polymerization strategy that presented the advantage of yielding in one step PCLyne with ca. 10%mol of propargylated units at a multigram scale and in one day. [11] This stable macrosynthon was advantageously used to prepare interpenetrating networks and amphiphilic copolymers using thiol-yne chemistry. [11] [12] [13] Herein, we report on a simple method to synthesize multifunctional polymers for advanced DDS by an original iterative procedure that consists of the sequential coupling of building blocks of interest to PCL-yne via a single thiol-yne photoaddition procedure (Scheme 1). Scheme 1. Illustration of (a) targeting DDS and (b) enzyme-responsive DDS design through iterative photoinduced functionalization of a PCL platform with selected building blocks.
Results and Discussion
In this work, we chose to apply our synthetic strategy to PCL-g-PEG graft copolymers to demonstrate the control offered by the iterative thiol-yne photoaddition to finely tune the composition. In the frame of DDS, such copolymers present the advantage of having lower critical micellar concentrations (CMC) over their linear analogues because of the side chains reducing their mobility and of their higher polydispersity. [13, 14] As a proof of concept, the building blocks bearing free thiol groups were selected i) to allow a control over the hydrophilicity of the system, ii) to impart targeting properties or enzyme-responsiveness and iii) to impart imaging/follow-up properties (Scheme 1). In more details, PEG was chosen as hydrophilic side chains, owing to its non-toxicity, biological inertness, and its well-known ability to confer stealthness to nanovectors. [15] PEG-cRGD was chosen as targeting group owing to the high binding affinity of cRGD oligopeptide (Scheme S1, SI) to tumor cells overexpressing RGD-integrin αvβ3 [16] in prostate, skin, ovary, lung, kidney and breast cancers. [17, 18] Tumor cells being known to overexpress matrix metalloproteinases (MMP), [19] PEG-MMPcp (PEG bearing a MMP cleavable peptide, Scheme 1) was chosen as an alternative building block. The aim was to get improved drug release from DDS at the vicinity or in cells overexpressing MMPs [20] and to promote cellular uptake thanks to the MMPtriggered loss of the sheddable hydrophilic shell. [21] Last, fluorescein was chosen as a fluorescent probe to assess the cellular uptake of the DDS.
For DDS with targeting properties (Scheme 1a), detailed synthetic procedures and a general scheme for the synthesis of the copolymers (Scheme S2, SI) can be found in the provided Supplementary Information. The iterative sequence was as follows. First, heterotelechelic PEG3k chains bearing one cRGD moiety and one free thiol were reacted with PCL-yne. This building block being the more sterically hindered it was the first to be reacted to ensure a more efficient coupling. To evaluate the influence of cRGD grafting density on the cellular binding efficacy two degrees of substitution (0.4 or 1.7 cRGD per PCL chain) were targeted. This was achieved by controlling the reaction parameters (details in Table S1, SI). The grafting density was calculated from 1H NMR analyses by comparison of the peaks at 2.3 ppm and 1.3 ppm of the PCL backbone with the peak at 3.6 ppm of the PEG (Figure   S1 , SI). In a second iteration, the overall hydrophilicity was tuned thanks to the use of shorter PEG 2k chains to guarantee the exposure of cRGD at the outer surface of the PEG layer on the final nanoobjects. Again, two EG/CL ratios (2.4 and 3.1) enabling self-assembly were selected and the targeted compositions were obtained using conditions previously established. [13] At this stage, a copolymer without cRGD and a EG/CL ratio of 3.2 was also prepared as a negative control. Finally, fluorescence was imparted by a final functionalization with a cysteamine spacer reacted with FITC. The success and extent of FITC labeling was confirmed by UV/visible spectroscopy.
Details on the copolymers composition, molecular weight and dispersity are provided in Table S2 (SI).
To investigate the potential of the PCL-g-(PEG-cRGD) copolymers as DDS, their selfassembly was first assessed using dynamic light scattering (DLS) measurements (Table S3 and Figure S3 , SI). For copolymers having EG/CL = 2.3-2.4, the intensity size distribution showed a bimodal behavior with a first mean hydrodynamic diameter FITC-labeled PCL-g-(PEG-cRGD) were incubated with two human prostate adenocarcinoma cell lines. PC-3 were selected as αvβ3 integrin high expression cell line, and compared to the LNCaP as αvβ3 integrin low expression cell line. [22, 23] For comparison purposes, nanoaggregates with the same EG/CL ratio and with similar sizes have been used (Table S3 entries 1 and 3, SI) and results of fluorescenceactivated cell sorting (FACS) analysis were expressed as percentage of median intensity of fluorescence (MIF) normalized with respect to FITC content. As expected, for the two levels of cRGD no difference was observed for the low integrin LNCaP cells (Figure 1a) . In contrast, for the PC-3 cell-line an improved uptake of the nanoaggregates was obtained for higher cRGD content with up to 60% higher uptake at a concentration of 100 µg/mL when increasing the cRGD ratio from 0.4 to 1.7. In another experiment, shorter incubation time and low content of cRGD (0.4) were used to account for the cRGD effect that is expected to induce fast adhesion.
Nanoaggregates with low or no cRGD content ( Table S3 entries This set of results, although preliminary, confirms the availability of the cRGD at the surface of the nanoaggregates for an improved cellular uptake. It also confirms the potential of the iterative photo thiol-yne strategy as a means to efficiently and easily modify copolymers to prepare targeting vectors with enhanced biological outcome.
To further illustrate the versatility of our iterative approach, and as a second proof of concept, this simple iterative procedure was used to yield DDS with enzymeresponsive properties. In fact, recent drug delivery strategies involve the use of matrix metalloproteinase cleavable oligopeptides as linkers for PEG-based block copolymers.
Such DDS, while presenting the advantages imparted by their PEG shell (stability, stealth properties), show improved cellular uptakes following the removal of their PEG corona in MMP rich environment as a consequence of an increase of their hydrophobicity that enhances interaction with cells and cell compartments. [21] In this work DDS with MMP-cleavable PEG shells (Scheme 1b) were easily obtained in a two-step iterative procedure by using the same fluorophore but replacing the targeting PEG-cRGD by PEG 0.75k chains end-functionalized with the MMPcp GPQGLAGQC that presents a free thiol on the C residue available for thiol-yne photoaddition (detailed synthetic procedures and structure provided in SI, Scheme S1and Scheme S3). This sequence is a substrate for MMPs overexpressed in many cancers and is selectively cleaved by MMP-9 between the G and L residues. [24] In opposition to targeting DDS, FITC labeling was chosen as a first step to minimize the use of PEG-GPQGLAGC derivative in this linear synthetic strategy. PCL-g-(MMPcp-PEG) with various contents of cleavable PEG side chains were then obtained by changing the initial ratio MMPcp-PEG/DMPA/PCL in the thiol-yne photoaddition ( Table S4 , SI). Additionally, it was confirmed that toxicity increased with increasing content of cleavable MMPcp-PEG chains (Figure S8 , SI). This set of results confirms the importance of PEG chains cleavage by the MMPs for an improved cellular uptake and subsequent cellular toxicity. In fact, in the hypothesis of a full removal of MMPcp-PEG chains from the sheddable nanoaggregates S4.7 the EG/CL ratio theoretically decreases from 1.9 to 1.4, which make them more hydrophobic than the non-sheddable nanoaggregates NS (EG/CL = 2). This higher hydrophobicity leads to an easier internalization and therefore higher cytotoxicity, in accordance with previously reported studies. [13, 21] Further experiments, including in vivo evaluation of the presented DDS, will be performed in the future to confirm these data.
Copolymers composition was calculated from 1 H NMR analyses as previously

Conclusions
In summary, this work reports the preparation of multifunctional copolymers thanks to an iterative photoinduced functionalization. A fine control over the sequence of functionalization and over the number of functional groups that can be introduced is made possible by a simple control of the reaction parameters. Based on the two proofs of concept reported in this communication, namely integrin-targeting and sheddable copolymers, it is our belief that the simple approach described here could be applied to various polymeric systems. It opens therefore new routes towards tunable advanced DDS that could be easily, and in a controlled manner, decorated with biologically relevant functionalities for improved biological outcomes.
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Synthesis of FITC-labeled PCL-g-(PEG-cRGD)
Synthesis of cRGD-PEG-SH
cRGD-PEG-NH 2 was kindly provided by Prof. Gilles Subra and Jérémy Ciccione. cRGD-PEG-NH 2 (PEG Mn = 3000 g/mol) was prepared following standard solid phase peptide synthesis on the SYNBIO3 platform. PEG immobilized solid support was used thus allowing the preparation of peptide-derivatized PEG with no trace of free PEG chains. cRGD-PEG- 
Synthesis of PCL-g-(PEG-cRGD)
Following the functionalization with cRGD-PEG chains, in order to further hydrophilize the graft copolymers, PEG-SH (PEG Mw = 2000 g/mol) was synthesized and grafted on propargylated PCL-g-PEG-RGD according to the conditions used in our previous work. 
FITC-labeled PCL-g-(PEG-cRGD)
In a typical experiment, PCL-g-(PEG-cRGD) copolymer (110 mg, including 50 mg of PCL backbone, ca. 34 µmol of initial alkyne groups) and Cys (116 mg, 30 eq. with respect to initial alkyne groups) were dissolved in 2 mL DMF in a Schlenk flask ( Table 2 , entry 3). In parallel, DMPA (25 mg, 3 eq. with respect to initial alkyne groups) was dissolved in 0.5 mL DMF in another Schlenk flask covered by aluminum foil. The 2 flasks were closed by septums after purging with argon for 10 min. The thiol-yne reaction was run as described above. The reaction mixture was purified by dialysis against water using dialysis membrane (MW cutoff 10000 Da). The cysteamine-functional copolymer was isolated after freeze-drying.
Cysteamine-functional copolymer (87 mg) was then dissolved in 7 mL of anhydrous ethanol and N,N-diisopropylethylamine (DIPEA) (28µl) was added. FITC (42 mg, 11 mmol) was dissolved in 4 mL of dry acetone and added to the copolymer solution. The mixture was covered by aluminum foil and stirred during the night at room temperature. After evaporation of acetone, the FITC-labeled copolymer was purified by dialysis against water by using a centrifugal filter unit (MW cutoff 10 000 Da). FITC-labeled PCL-g-(PEG-cRGD) was isolated after freeze-drying. FITC content was assessed by UV/vis spectrometry at 497 nm.
Quantification was performed with respect to a calibration curve of FITC in acetone.
Synthesis of FITC-labeled PCL-g-(MMPcp-PEG)
FITC-labeled PCL
PCL-yne (800 mg; 0.55 mmol alkyne groups) was dissolved with Cys (31 mg; 0.27 mmol) in 
Synthesis of FITC-labeled PCL-g-(MMPcp-PEG)
PEG-MMPcp-SH was kindly provided by Prof. Gilles Subra and Jérémy Ciccione. PEG-MMPcp-SH (PEG Mn = 750 g/mol ; MMP cleavable peptide = GPQGLAGQC) was prepared following standard solid phase peptide synthesis on the SYNBIO3 platform. FITC-labeled PCL-g-(MMPcp-PEG) was obtained by thiol-yne reaction of FITC-labeled PCL and PEG-MMPcp-SH. Typically, FITC-labeled PCL (20 mg) and PEG-MMPcp-SH (140 mg; 6 eq with respect to initial alkyne groups) were dissolved in 1.5 mL DMF in a Schlenk flask. Similarly, DMPA (10 mg, 4 eq. with respect to initial alkyne groups) was dissolved in 0.5 mL DMF in a Schlenk flask covered by aluminum foil. The 2 flasks were closed by septums after purging with argon for 10 min. The thiol-yne reaction medium was done as described above. The reaction mixture was purified by dialysis against water by a centrifugal filter unit (MW cutoff 10 000 Da). The copolymer was finally freeze-dried.
Copolymer notations
For sake of clarity, the following notations are used to identify the various copolymers:
PCL-g-PEG X ; PCL-g-(PEG X -cRGD Y ); PCL-g-(MMPcp Y -PEG X ) with X the value of the EG/CL ratio representing the hydrophilic/hydrophobic balance of the copolymer and Y the number of cRGD or MMPcp moieties per copolymer.
Preparation of nanoaggregates
Preparation of targeting nanoaggregates
Nanoaggregates were prepared by the self-assembly method according to our previous work. 2 In brief, selected PCL-g-(PEG X -cRGD Y ) (10 mg) was dissolved in 2 mL of acetone, and then poured into 10 mL of PBS. Nanoaggregates spontaneously formed following the slow evaporation of acetone under atmospheric pressure.
Preparation of MMP sensitive nanoaggregates
In brief, for blank nanoaggregates selected PCL-g-(MMPcp Y -PEG X ) (5 mg) and PCL-g-PEG (5 mg, PEG 2k side chains, EG/CL = 4.2) were dissolved in 2 mL of acetone, and then poured into 10 mL of PBS. The slow evaporation of acetone under atmospheric pressure and then under vacuum allows the formation of nanoaggregates.
Curcumin loaded nanoaggregates were also prepared by the self-assembly method. Typically, curcumin (1.4 mg), PCL-g-(MMPcp Y -PEG X ) (5 mg) and PCL-g-PEG (5 mg, PEG 2k side chains, EG/CL = 4.2) were dissolved in 0.5 mL acetone. Then 4.5 mL of PBS were added. The mixture was stirred one hour using an Ultra-Turrax stirrer (8000 rpm). The remaining acetone was evaporated under vacuum. The solution was then centrifuged for 10 min at 3600 rpm and 20°C before filtration through a 0.45 μm filter to eliminate the unloaded drug.
Determination of drug loading and encapsulation efficiency
Drug loading (DL) was determined by UV/Vis spectrophotometry at 425 nm. Quantification was performed with respect to a calibration curve of curcumin in acetone/water (20:80). The -25 -
Cytotoxicity assays
Transfected HEK293-β3 cells were procured from Jean-Luc COLL's lab, Albert Bonniot Institute, Grenoble. The human embryonic HEK293 has been stably transfected with β3 thus forming the HEK293-β3 cell line. HEK293-β3 cells overexpressed integrin β3 chain lead to an increased level of MMP-2 and MMP-9 expression. 3 Cells were maintained in DMEM supplemented with 10% FBS and 1% penicillin / streptomycin at 37°C in a humidified incubator containing 5% CO 2 .
The cytotoxicity of the nanoaggregates was assessed using Prestoblue® Cell viability reagent (Invitrogen). For this assay, cells were seeded at 4.10 4 cells per well into a 24-well plate and allowed to attach overnight. They were then treated with 7 and 15 µg/mL of curcumin encapsulated in the nanoaggregates (dissolved in PBS) for 24h and 48h. Appropriate equivalent amounts of nanoparticles without curcumin were run simultaneously. Also medium containing equivalent amounts of PBS or medium only were used as a control ( Figure S4 ).
Cell viability was measured using Prestoblue® Cell viability reagent according to manufacturer's instruction. Briefly, 10% of Prestoblue® was diluted into cell growth medium.
When added to cells, the reagent is modified by the reducing environment of the viable cells and turns red in color, becoming highly fluorescent. After incubation time, supernatant was transferred to a 96-well plate and the fluorescence was measured at 560/590nm using a microplate reader (PerkinElmer, Victor3V). Data are expressed as means ± SD and correspond to measurements in triplicate. 
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